Glaucoma: genes, phenotypes, and new directions for therapy.
Glaucoma, a leading cause of blindness worldwide, is characterized by progressive optic nerve damage, usually associated with intraocular pressure. Although the clinical progression of the disease is well defined, the molecular events responsible for glaucoma are currently poorly understood and current therapeutic strategies are not curative. This review summarizes the human genetics and genomic approaches that have shed light on the complex inheritance of glaucoma genes and the potential for gene-based and cellular therapies that this research makes possible.
Fan
Bao Jian
BJ
Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA.
Wiggs
Janey L
JL
D001766:Blindness / Q000235:genetics / Q000628:therapy; D018450:Disease Progression; D005123:Eye / Q000033:anatomy & histology / Q000473:pathology; D005544:Forecasting; D008040:Genetic Linkage; D005901:Glaucoma / Q000188:drug therapy / Q000235:genetics* / Q000628:therapy*; D006801:Humans; D007429:Intraocular Pressure; D009900:Optic Nerve / Q000473:pathology; D010641:Phenotype; D014065:Tonometry, Ocular
Clin Biochem. 2006 Mar;39(3):231-9
16412407
Nat Genet. 1998 May;19(1):47-50
9590287
Arch Ophthalmol. 2001 Nov;119(11):1674-8
11709019
Exp Eye Res. 2009 Apr;88(4):704-12
18804106
Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1459-63
18385063
Surv Ophthalmol. 2007 Nov;52 Suppl 2:S155-61
17998041
Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2542-6
16723468
Mol Ther. 2010 Mar;18(3):491-501
19953083
Hum Genet. 2003 May;112(5-6):600-9
12616399
Hum Mol Genet. 1996 Aug;5(8):1199-203
8842741
Arch Ophthalmol. 2010 Apr;128(4):466-71
20385943
Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13469-74
19805021
Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2773-80
18281610
Lancet. 2009 Nov 7;374(9701):1597-605
19854499
Arch Ophthalmol. 2007 Jan;125(1):86-92
17210857
Mol Vis. 2008 Sep 05;14:1659-65
18776954
Invest Ophthalmol Vis Sci. 2010 Jan;51(1):327-34
19710411
Invest Ophthalmol Vis Sci. 2007 Jul;48(7):3209-15
17591890
Arch Ophthalmol. 2008 Mar;126(3):420-1
18332326
Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4453-7
18586872
Invest Ophthalmol Vis Sci. 2009 Nov;50(11):5275-80
19458335
Br J Ophthalmol. 2006 Dec;90(12):1505-9
16825280
Mol Vis. 2004 Nov 09;10:851-6
15547491
Genomics. 1995 Nov 20;30(2):171-7
8586416
Arch Ophthalmol. 1999 Feb;117(2):237-41
10037570
Trans Am Ophthalmol Soc. 2009 Dec;107:127-33
20126489
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12838-42
19625618
Nat Genet. 1993 May;4(1):47-50
8513321
Mol Vis. 2010 Apr 21;16:705-12
20431720
Invest Ophthalmol Vis Sci. 2008 May;49(5):1932-9
18436825
Clin Genet. 2002 Feb;61(2):79-88
11940081
Hum Mol Genet. 2002 May 15;11(10):1161-7
12015275
Hum Mol Genet. 1997 Apr;6(4):641-7
9097971
Mol Vis. 2002 Apr 24;8:127-9
12011806
J Glaucoma. 2005 Aug;14(4):318-20
15990617
Am J Hum Genet. 1996 Jan;58(1):243-4
8554064
Mol Vis. 2006 Feb 14;12:85-92
16518310
Am J Hum Genet. 2009 May;84(5):664-71
19361779
Am J Hum Genet. 1998 Nov;63(5):1549-52
9792882
Arch Ophthalmol. 1997 Mar;115(3):384-8
9076212
Invest Ophthalmol Vis Sci. 2010 Jun;51(6):3029-41
20089870
Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):17105-10
19805132
Am J Hum Genet. 1996 Sep;59(3):613-9
8751862
Invest Ophthalmol Vis Sci. 2010 Jan;51(1):236-48
19684004
Stem Cells. 2010 Apr;28(4):695-703
20166150
Exp Eye Res. 2010 Jul;91(1):48-53
20394744
Eye (Lond). 2000 Jun;14 ( Pt 3B):422-8
11026969
Hum Mol Genet. 2008 Aug 15;17(16):2474-85
18469340
Graefes Arch Clin Exp Ophthalmol. 2006 Aug;244(8):984-90
16411107
Expert Rev Mol Med. 2005 Nov 08;7(25):1-17
16274491
Invest Ophthalmol Vis Sci. 2002 Jun;43(6):1820-7
12036985
Ophthalmology. 2009 Jul;116(7):1243-9
19450880
Genomics. 1996 Aug 15;36(1):142-50
8812425
J Glaucoma. 2006 Jun;15(3):218-22
16778644
Arch Ophthalmol. 2007 Jan;125(1):30-7
17210849
Invest Ophthalmol Vis Sci. 2010 Jun;51(6):2968-75
20107165
J Glaucoma. 2009 Jan;18(1):73-8
19142139
Invest Ophthalmol Vis Sci. 2009 Dec;50(12):5712-7
19553612
Invest Ophthalmol Vis Sci. 2004 Jan;45(1):59-62
14691154
Hum Mol Genet. 2010 Jul 1;19(13):2716-24
20395239
Nat Genet. 1996 Dec;14(4):392-9
8944018
Invest Ophthalmol Vis Sci. 2003 Oct;44(10):4357-65
14507880
BMC Med Genet. 2008 Feb 06;9:5
18254956
Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3262-7
16877390
Am J Hum Genet. 1997 Feb;60(2):296-304
9012402
Science. 1997 Jan 31;275(5300):668-70
9005853
Ophthalmology. 2010 Feb;117(2):267-74
19969364
Neuroscience. 2009 Aug 18;162(2):375-82
19422885
Hum Mol Genet. 2008 Mar 1;17(5):710-6
18037624
Am J Hum Genet. 2004 Jun;74(6):1314-20
15108121
Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5368-75
17122126
Ophthalmology. 2007 Jan;114(1):10-9
17095090
Hum Genet. 2008 Jan;122(6):589-93
17924146
Am J Hum Genet. 1998 Nov;63(5):1316-28
9792859
Am J Med Genet. 2002 Aug 1;111(2):182-6
12210347
Science. 2003 Mar 7;299(5612):1578-81
12624268
Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1607-14
17389490
Mol Vis. 2006 Jun 12;12:673-80
16785856
Science. 2007 Sep 7;317(5843):1397-400
17690259
Mol Vis. 2009 Jun 04;15:1120-6
19503743
Mol Vis. 2007 May 23;13:779-84
17563728
Mol Diagn. 2004;8(4):245-52
15887980
Eye (Lond). 2008 Jun;22(6):838-43
17293784
Arch Ophthalmol. 2007 Jan;125(1):74-9
17210855
Invest Ophthalmol Vis Sci. 2005 Jun;46(6):2002-5
15914615
Surv Ophthalmol. 2009 Jul-Aug;54(4):472-86
19539835
BMC Med Genet. 2009 Sep 15;10:91
19754948
J Clin Lab Anal. 2003;17(6):259-63
14614750
Br J Ophthalmol. 2006 Mar;90(3):262-7
16488940
Ophthalmol Clin North Am. 2003 Dec;16(4):639-45
14741004
Mol Vis. 2006 Aug 29;12:1016-21
16971893
Annu Rev Pharmacol Toxicol. 2008;48:333-58
17914928
Prog Brain Res. 2008;173:511-9
18929131
Arch Ophthalmol. 2010 Mar;128(3):276-87
20212196
Hum Mol Genet. 2009 Oct 15;18(20):3969-77
19656777
Hum Mol Genet. 2000 Apr 12;9(7):1109-17
10767336
Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5315-21
17122119
Invest Ophthalmol Vis Sci. 2010 Aug;51(8):4110-6
20357201
Am J Ophthalmol. 1998 Jul;126(1):17-28
9683145
Methods Enzymol. 2008;438:11-24
18413238
Invest Ophthalmol Vis Sci. 2010 Jan;51(1):72-8
19696176
Clin Exp Ophthalmol. 2009 Mar;37(2):201-7
19723129
Ophthalmology. 1996 May;103(5):808-14
8637692
Invest Ophthalmol Vis Sci. 2010 Feb;51(2):971-9
19815736
Hum Mol Genet. 2005 Mar 15;14(6):725-33
15677485
Nat Genet. 2002 Jan;30(1):81-5
11743578
Exp Eye Res. 2009 Apr;88(4):747-51
19061887
Hum Genet. 2010 Jan;127(1):33-44
19714363
Science. 2002 Feb 8;295(5557):1077-9
11834836
Nat Genet. 2004 Feb;36(2):178-82
14745449
Mol Cell Biol. 2001 Nov;21(22):7707-13
11604506
Arch Ophthalmol. 1997 Feb;115(2):182-5
9046252
Hum Mol Genet. 2010 Jul 1;19(13):2606-15
20388642
Am J Pathol. 2010 Jun;176(6):2880-90
20382707
Am J Hum Genet. 1998 Nov;63(5):1411-8
9792868
Invest Ophthalmol Vis Sci. 2010 Apr;51(4):2051-9
19933193
Clin Exp Ophthalmol. 2008 Dec;36(9):868-82
19278484
Invest Ophthalmol Vis Sci. 2008 Sep;49(9):3976-80
18450598
Exp Eye Res. 2009 Apr;88(4):808-15
19217904
J Biol Chem. 2005 Dec 30;280(52):42848-55
16251195
Invest Ophthalmol Vis Sci. 2009 Sep;50(9):4244-53
19357352
Hum Mol Genet. 2000 Apr 12;9(7):1021-32
10767326
Invest Ophthalmol Vis Sci. 2005 Aug;46(8):2816-22
16043855
Mol Vis. 2010 Jan 11;16:18-25
20069064
J Med Genet. 2010 Feb;47(2):120-5
19581274
Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9553-8
15976030
Am J Hum Genet. 2009 Oct;85(4):447-56
19765683
Ophthalmology. 2009 Apr;116(4):710-6, 716.e1-82
19344823
Exp Eye Res. 2008 Apr;86(4):543-61
18313051
Ophthalmology. 1995 Dec;102(12):1782-9
9098278
J Glaucoma. 2006 Oct;15(5):358-63
16988596
Exp Eye Res. 2009 Apr;88(4):648-55
19239914
Am J Hum Genet. 1998 Feb;62(2):325-33
9463332
Invest Ophthalmol Vis Sci. 2009 May;50(5):2194-200
19060281
Vis Neurosci. 2008 Jul-Aug;25(4):563-74
18764959
Genomics. 1997 May 1;41(3):360-9
9169133
Int J Dev Biol. 2004;48(8-9):1015-29
15558492
Drug Discov Today. 2010 Apr;15(7-8):287-99
20197108
Hum Mol Genet. 1999 May;8(5):899-905
10196380
Clin Biochem. 2006 Mar;39(3):249-58
16332362
Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3669-76
17652737
Invest Ophthalmol Vis Sci. 2006 Apr;47(4):1486-90
16565383
Invest Ophthalmol Vis Sci. 2009 Sep;50(9):4087-90
19420341